Centrum Badan Klinicznych

Wroclaw 51-162

1 studies enrolling now · 10 studies all time

What they study most

Cardiovascular Risk, Chronic Kidney Disease, Crohn's Disease, Diabetes Mellitus, Type 2, HBeAg-positive Chronic Hepatitis B, Hepatocellular Carcinoma (HCC), Inflammation, Non-Alcoholic Steatohepatitis (NASH), Non-alcoholic Steatohepatitis, Peripheral Arterial Disease, Respiratory Syncytial Virus Infection, Type 2 Diabetes Mellitus

Studies at this site

• A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) — Running, not enrolling
• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
• A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes — Running, not enrolling
• A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes — Completed
• Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH) — Completed
• A Study of Tislelizumab Versus Sorafenib in Participants With Unresectable Hepatocellular Carcinoma (HCC) — Completed
• Study to Compare Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF) in Participants With Chronic Hepatitis B Infection Who Are Positive for Hepatitis B e Antigen — Completed
• Phase 2b Study in NASH to Assess IVA337 — Completed
• Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection — Completed